Sign In
Buy RMD
$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
Could GLP-1 Drugs Make ResMed's CPAP Machines Obsolete?
02:00pm, Wednesday, 12'th Nov 2025
GLP-1 drugs pose an existential threat to CPAP-makers. ResMed is currently experiencing temporary tailwinds before potential long-term headwinds.
Oppenheimer Asset Management Inc. Cuts Stock Position in ResMed Inc. $RMD
03:36am, Sunday, 02'nd Nov 2025
Oppenheimer Asset Management Inc. cut its holdings in ResMed Inc. (NYSE: RMD) by 77.6% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional inv
Resmed Stock Up on Q1 Earnings & Revenue Beat, Margins Expand
09:26am, Friday, 31'st Oct 2025
RMD's Q1 earnings and revenues top estimates as solid device and mask sales lift margins and boost investor confidence.
These Analysts Revise Their Forecasts On ResMed Following Q1 Results
09:24am, Friday, 31'st Oct 2025
ResMed Inc. (NYSE:RMD) reported better-than-expected earnings for the first quarter on Thursday.
ResMed Inc. (RMD) Q1 2026 Earnings Call Transcript
10:16pm, Thursday, 30'th Oct 2025
ResMed Inc. ( RMD ) Q1 2026 Earnings Call October 30, 2025 4:30 PM EDT Company Participants Sallilyn Schwartz - Chief Investor Relations Officer Michael Farrell - CEO & Chairman Brett Sandercock - Chi
Compared to Estimates, ResMed (RMD) Q1 Earnings: A Look at Key Metrics
06:30pm, Thursday, 30'th Oct 2025
While the top- and bottom-line numbers for ResMed (RMD) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare
ResMed (RMD) Q1 Earnings and Revenues Beat Estimates
06:16pm, Thursday, 30'th Oct 2025
ResMed (RMD) came out with quarterly earnings of $2.55 per share, beating the Zacks Consensus Estimate of $2.49 per share. This compares to earnings of $2.2 per share a year ago.
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026
04:05pm, Thursday, 30'th Oct 2025
Revenue increased by 9% to $1.3 billion; up 8% on a constant currency basis Gross margin up 290 bps to 61.5%; non-GAAP gross margin up 280 bps to 62.0% Income from operations increased 15%; non-G
Seeking Clues to ResMed (RMD) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
10:16am, Wednesday, 29'th Oct 2025
Besides Wall Street's top-and-bottom-line estimates for ResMed (RMD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quart
Cullen Frost Bankers Inc. Raises Stake in ResMed Inc. $RMD
04:20am, Sunday, 26'th Oct 2025
Cullen Frost Bankers Inc. grew its stake in shares of ResMed Inc. (NYSE: RMD) by 34.3% during the undefined quarter, according to its most recent 13F filing with the SEC. The institutional investor ow
ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:05am, Thursday, 23'rd Oct 2025
ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why ResMed (RMD) is a Strong Growth Stock
10:45am, Monday, 20'th Oct 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
4 GARP Stocks That Investors Can Scoop Up for Maximum Returns
11:51am, Friday, 17'th Oct 2025
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. SYK, NVDA, RMD and RL hold promise.
5 Low-Leverage Stocks to Buy as Market Takes a Tumble
11:36am, Friday, 10'th Oct 2025
As markets tumble, low-leverage stocks like RMD, SAFRY, PNR, CASY, and DRS offer safer investment options for steady returns.
Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025
04:05pm, Thursday, 09'th Oct 2025
SAN DIEGO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2026 on Thursday, O
